The Proposed Inflammatory Pathophysiology of Rosacea: Implications for Treatment
- 1 January 2003
- journal article
- review article
- Published by Wiley in SKINmed: Dermatology for the Clinician
- Vol. 2 (1) , 43-47
- https://doi.org/10.1111/j.1540-9740.2003.01876.x
Abstract
The pathophysiology of the vascular and inflammatory stages of facial rosacea and proposes an underlying cause is reviewed. It can be argued that all the stigmata of rosacea are manifestations of an inflammatory process: neutrophilic dermatosis. For this reason, treatments that block neutrophil involvement in the development of rosacea, such as topical metronidazole and systemic antibodies, should be considered first‐line therapy for all stages of the disease.Keywords
This publication has 20 references indexed in Scilit:
- Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosaceaJournal of the American Academy of Dermatology, 2001
- Increased density of Demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosaceaJournal of the European Academy of Dermatology and Venereology, 2001
- ACNE AND ROSACEA: New and Emerging TherapiesDermatologic Clinics, 2000
- ACNE ROSACEA AND HELICOBACTER PYLORI BETROTHEDInternational Journal of Dermatology, 1995
- RosaceaArchives of Dermatology, 1994
- Why is flushing limited to a mostly facial cutaneous distribution?Journal of the American Academy of Dermatology, 1988
- RosaceaJournal of Investigative Dermatology, 1987
- Rosacea: Disease or Reaction Pattern?Dermatology, 1986
- Flushing Reactions: Consequences and MechanismsAnnals of Internal Medicine, 1981
- CONCEPTS IN THE PATHOGENESIS OF ROSACEABritish Journal of Dermatology, 1968